Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -104,327 | -94,347 | -66,738 | -42,211 | -33,167 |
| Depreciation Amortization | 1,966 | 1,801 | 626 | 754 | 403 |
| Accounts receivable | 1,959 | -11,563 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -924 | -2,770 | 4,088 | 205 | -343 |
| Other Working Capital | -3,573 | -11,938 | 2,383 | 1,944 | 1,680 |
| Other Operating Activity | 14,205 | 26,097 | 5,520 | 5,210 | 4,079 |
| Operating Cash Flow | $-90,694 | $-92,720 | $-54,121 | $-34,098 | $-27,348 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -76,267 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,942 | -1,335 | -1,578 | -480 | -153 |
| Investing Cash Flow | $-78,209 | $-1,335 | $-1,578 | $-480 | $-153 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 74,655 | 10,000 | 1,333 |
| Debt Repayment | -32 | -30 | -21,847 | -1,111 | -1,333 |
| Common Stock Issued | 160,660 | 9,012 | 71,296 | 94,807 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 67,214 |
| Financing Cash Flow | $160,628 | $8,982 | $124,104 | $103,696 | $67,214 |
| Beginning Cash Position | 98,031 | 183,104 | 114,699 | 45,581 | 5,868 |
| End Cash Position | 89,756 | 98,031 | 183,104 | 114,699 | 45,581 |
| Net Cash Flow | $-8,275 | $-85,073 | $68,405 | $69,118 | $39,713 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,694 | -92,720 | -54,121 | -34,098 | -27,348 |
| Capital Expenditure | -1,942 | -1,335 | -1,578 | -480 | -153 |
| Free Cash Flow | -92,636 | -94,055 | -55,699 | -34,578 | -27,501 |